Skip to main content

Interventional Cardiology Market is Increasing at a Perfect CAGR of 5.4% During Forecast to 2025


Market Analysis:

Various factors are adding to the global interventional cardiology market share. These factors, as per the new MRFR report, include increasing geriatric population, preference for minimally invasive procedures, growing awareness created by key players and medical professionals regarding the benefits of interventional cardiology procedures, increasing investment in R&D, incorporation of innovations in cardiac intervention industries, collaborations and partnerships between local players and key players, support by government organizations, and favorable reimbursement scenario especially in developed countries. Besides, increasing cases of cardiac disease and technological advances in interventional cardiac devices are also adding to the interventional cardiology devices market growth. 

The Interventional Cardiology Market Size was valued USD 15,130.75 million in 2018 and is predicted to grow at a 5.4% CAGR between 2019- 2025, reveals the new Market Research Future (MRFR) report. Interventional cardiology, simply put, is a branch of cardiology that deals with structural heart disease treatment that is catheter-based. 


On the contrary, the risk of bloodstream infections and product recalls are factors that may limit the interventional cardiology market growth over the forecast period. 

Key Players:

W. L. Gore & Associates, Inc. (US), Terumo Corporation (Japan), Merit Medical Systems, Inc (US), Medtronic (Ireland), Life Vascular Devices Biotech S.L. (Spain), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Edwards Lifesciences Corporation (US), Cook Medical (US), Cardinal Health (US), Boston Scientific Corporation (US), Biotronik SE & Co. KG (Germany), Biosense Webster, Inc (US), BD (US), B. Braun Melsungen AG (Germany), ACIST Medical Systems, Inc. (the US), Abbott (US), and ABIOMED (US). 

Market Segmentation:

·         The Market Research Future Report provides an inclusive segmental analysis of the global interventional cardiology market based on end user and type. 

·         By type, the interventional cardiology market is segmented into coronary guidewires, plaque modification devices, percutaneous transluminal coronary angioplasty (PTCA) catheters, stents, and accessories. Stents are again segmented into bioresorbable vascular scaffolds, bare-metal stents, and drug-eluting stents. PTCA catheters are again segmented into guiding catheters and balloon catheters. Of these, the stents segment will lead the market over the forecast period for the rising number of product launches by industry players lately, constant innovation by players, and rising cases of coronary artery disease. 

·         By end user, the interventional cardiology market is segmented into ambulatory surgical centers, cardiac catheterization laboratories, hospitals, and others. Of these, hospitals will spearhead the market over the forecast period for the increase in patient admissions in hospitals for coronary diseases. This will be followed by the cardiac catheterization laboratory segment, which is likely to grow at a fast pace for its rising preference by medical professionals. 

Regional Analysis:
Based on the region, the global interventional cardiology market report covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East & Africa (RoW). Of these, the Americas will spearhead the market over the forecast period for the rising prevalence of coronary diseases in the region. Besides, the presence of top market players is also adding market growth. 

The interventional cardiology market in Europe is predicted to possess the second-largest share over the forecast period for the rising number of hospitalizations for cerebral angioplasty and carotid artery angioplasty. 

The interventional cardiology market in the APAC region is predicted to grow at a fast pace over the forecast period for an increasing number of collaborations and partnerships, rising number of setups of R&D centers, robust marketing initiatives undertaken by the manufacturers, and consumers helping to increase the target audience. 

The interventional cardiology market in the MEA is predicted to hold the smallest share over the forecast period yet is likely to grow owing to the focus of industry players on untapped regions. 


NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.


Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more